Clínica Baviera, S.A. (CBAV.MC)
EUR 31.4
(-1.26%)
EUR 31.4
(-1.26%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 503.02 Thousand EUR | -98.68% |
| 2022 | 37.97 Million EUR | -4.81% |
| 2021 | 39.89 Million EUR | -4.36% |
| 2020 | 41.7 Million EUR | -0.13% |
| 2019 | 41.76 Million EUR | 442.11% |
| 2018 | 7.7 Million EUR | -18.47% |
| 2017 | 9.44 Million EUR | -14.62% |
| 2016 | 11.06 Million EUR | 12.65% |
| 2015 | 9.82 Million EUR | -15.51% |
| 2014 | 11.62 Million EUR | 87.3% |
| 2013 | 6.2 Million EUR | -37.1% |
| 2012 | 9.87 Million EUR | -25.72% |
| 2011 | 13.28 Million EUR | -1.83% |
| 2010 | 13.53 Million EUR | -22.91% |
| 2009 | 17.55 Million EUR | 0.51% |
| 2008 | 17.47 Million EUR | 300.44% |
| 2007 | 4.36 Million EUR | -28.2% |
| 2006 | 6.07 Million EUR | -32.36% |
| 2005 | 8.98 Million EUR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 46.49 Million EUR | 300.98% |
| 2024 Q2 | - EUR | -100.0% |
| 2023 Q4 | 36.66 Million EUR | -21.26% |
| 2023 Q2 | 1.51 Million EUR | 0.0% |
| 2023 Q1 | - EUR | -100.0% |
| 2023 Q3 | 46.55 Million EUR | 2979.23% |
| 2023 FY | 503.02 Thousand EUR | -98.68% |
| 2022 Q2 | 4.59 Million EUR | -90.33% |
| 2022 Q1 | 47.54 Million EUR | 19.18% |
| 2022 FY | 37.97 Million EUR | -4.81% |
| 2022 Q4 | 37.97 Million EUR | -12.52% |
| 2022 Q3 | 43.4 Million EUR | 844.2% |
| 2021 Q1 | 54.94 Million EUR | 31.73% |
| 2021 Q3 | 49.46 Million EUR | 490.38% |
| 2021 Q4 | 39.89 Million EUR | -19.35% |
| 2021 Q2 | 8.37 Million EUR | -84.75% |
| 2021 FY | 39.89 Million EUR | -4.36% |
| 2020 Q1 | 61.34 Million EUR | 46.88% |
| 2020 Q2 | 13.31 Million EUR | -78.3% |
| 2020 Q3 | 56.49 Million EUR | 324.43% |
| 2020 Q4 | 41.7 Million EUR | -26.17% |
| 2020 FY | 41.7 Million EUR | -0.13% |
| 2019 Q2 | 9.66 Million EUR | -79.92% |
| 2019 FY | 41.76 Million EUR | 442.11% |
| 2019 Q3 | 55.05 Million EUR | 469.78% |
| 2019 Q4 | 41.76 Million EUR | -24.14% |
| 2019 Q1 | 48.11 Million EUR | 524.55% |
| 2018 Q2 | 9.97 Million EUR | 0.0% |
| 2018 Q4 | 7.7 Million EUR | -51.53% |
| 2018 FY | 7.7 Million EUR | -18.47% |
| 2018 Q3 | 15.89 Million EUR | 59.29% |
| 2017 Q4 | 9.44 Million EUR | 0.0% |
| 2017 FY | 9.44 Million EUR | -14.62% |
| 2017 Q2 | 14.55 Million EUR | -11.1% |
| 2017 Q1 | 16.37 Million EUR | 47.97% |
| 2016 Q4 | 11.06 Million EUR | 0.0% |
| 2016 Q2 | 11.58 Million EUR | 0.0% |
| 2016 FY | 11.06 Million EUR | 12.65% |
| 2015 FY | 9.82 Million EUR | -15.51% |
| 2015 Q2 | 13.9 Million EUR | 0.0% |
| 2015 Q4 | 9.82 Million EUR | 0.0% |
| 2014 Q2 | 11.45 Million EUR | 0.0% |
| 2014 FY | 11.62 Million EUR | 87.3% |
| 2014 Q4 | 11.62 Million EUR | 0.0% |
| 2013 Q4 | 6.2 Million EUR | 0.0% |
| 2013 Q2 | 11.12 Million EUR | 0.0% |
| 2013 FY | 6.2 Million EUR | -37.1% |
| 2012 FY | 9.87 Million EUR | -25.72% |
| 2012 Q2 | 15.55 Million EUR | 0.0% |
| 2012 Q4 | 9.87 Million EUR | 0.0% |
| 2011 FY | 13.28 Million EUR | -1.83% |
| 2011 Q2 | 18.79 Million EUR | 0.0% |
| 2011 Q4 | 13.28 Million EUR | 0.0% |
| 2010 Q2 | - EUR | 0.0% |
| 2010 FY | 13.53 Million EUR | -22.91% |
| 2010 Q4 | 13.53 Million EUR | 0.0% |
| 2009 FY | 17.55 Million EUR | 0.51% |
| 2009 Q4 | 17.55 Million EUR | 0.0% |
| 2008 FY | 17.47 Million EUR | 300.44% |
| 2007 FY | 4.36 Million EUR | -28.2% |
| 2006 FY | 6.07 Million EUR | -32.36% |
| 2005 FY | 8.98 Million EUR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Pangaea Oncology, S.A. | 1.86 Million EUR | 73.009% |